SCHEMBL4529276

SCHEMBL4529276

O=C(O)CNCC(=O)Nc1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.63
CA2 P00918 5/20 0.63
L3MBTL1 Q9Y468 2/20 0.59
EPHX2 P34913 3/20 0.55
ABAT P80404 1/20 0.55
MAPT P10636 2/20 0.52
HTT P42858 1/20 0.52
RECQL P46063 1/20 0.51
HDAC1 Q13547 1/20 0.50
TP53 P04637 1/20 0.50
EPHX1 P07099 1/20 0.50
TSHR P16473 1/20 0.50
CDK9 P50750 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CLK4 Q9HAZ1 1/20 0.50
KDM1A O60341 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
GAA P10253 1/20 0.50
SCN1A P35498 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23660445 0.82 EPHX2 (0.53) L3MBTL1EPHX2MAPTHTTRECQL
SCHEMBL14107963 0.82 MAPT (0.58) L3MBTL1EPHX2MAPTRECQLSMN1; SMN2
Acetanilide SCHEMBL11221126 0.82 NAPRT (0.73) L3MBTL1ABATMAPTHTTEPHX1
SCHEMBL27852723 0.81 RECQL (0.74) EPHX2MAPTHTTRECQLMEN1
SCHEMBL5913640 0.81 HDAC1 (0.55) CA1CA2L3MBTL1EPHX2MAPT
SCHEMBL2555157 0.80 CA1 (0.59) CA1CA2MAPTSMN1; SMN2MEN1
SCHEMBL15332168 0.80 KMT2A (0.62) CA1CA2L3MBTL1MAPTHTT
SCHEMBL28961967 0.79 ALDH1A1 (0.51) L3MBTL1EPHX2MAPTHTTRECQL
SCHEMBL8520467 0.79 KDM4E (0.59) L3MBTL1EPHX2MAPTHTTRECQL
SCHEMBL23178156 0.79 GAA (0.67) L3MBTL1EPHX2MAPTRECQLHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102653158-B Lithographic printing plate precursor and plate making method thereof FUJIFILM CORP 2015-04-15 CN disclosed
US-8314121-B2 Imidazolone derivatives, preparation thereof as drugs, pharmaceutical compositions, and use thereof as protein kinase inhibitors, in particular CDC7 SANOFI (FR) 2012-11-20 US disclosed
CN-102653158-A Lithographic printing plate precursor and plate making method thereof FUJIFILM CORP 2012-09-05 CN disclosed
US-20090253679-A1 NEW IMIDAZOLONE DERIVATIVES, PREPARATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF AS PROTEIN KINASE INHIBITORS, IN PARTICULAR CDC7 SANOFI-AVENTIS (FR) 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253679-A1 NEW IMIDAZOLONE DERIVATIVES, PREPARATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF AS PROTEIN KINASE INHIBITORS, IN PARTICULAR CDC7 CDC7, CDK7, CDK17 CA1 4606/4885CA2 3446/4885L3MBTL1 4256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.